Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA

Lignende værker

• Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
  af: Xuan Guoyun, et al.
  Udgivet: (2022-08-01)
• Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
  af: Kazufumi Dohmen, et al.
  Udgivet: (2021-10-01)
• Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis
  af: Wei Lin, et al.
  Udgivet: (2024-01-01)
• Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
  af: Mohammad Alomari, et al.
  Udgivet: (2020-04-01)
• New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
  af: Jhaveri MA, et al.
  Udgivet: (2017-08-01)